Valuation : Cogstate Limited

Market Cap 510M 366M 315M 298M 270M 507M 34.93B 3.54B 1.36B 17.77B 1.37B 1.34B 56.15B P/E 2027 *
23.9x
P/E 2028 * 19.6x
Enterprise Value 448M 321M 277M 262M 238M 446M 30.69B 3.11B 1.2B 15.61B 1.21B 1.18B 49.34B EV / Sales 2027 *
4.18x
EV / Sales 2028 * 3.56x
Free-Float
56.23%
Yield 2027 *
1.76%
Yield 2028 * 2.12%
1 day-0.33%
1 week-2.28%
Current month-2.60%
1 month+12.36%
3 months+7.53%
6 months+29.31%
Current year+32.74%
1 week 2.95
Extreme 2.95
3.13
1 month 2.62
Extreme 2.62
3.23
Current year 2.01
Extreme 2.01
3.23
1 year 1.75
Extreme 1.75
3.23
3 years 0.8
Extreme 0.795
3.23
5 years 0.8
Extreme 0.795
3.23
10 years 0.16
Extreme 0.155
3.23
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/12/1999
Chief Executive Officer - 01/12/2005
Director of Finance/CFO - 01/02/2021
Director TitleAgeSince
Director/Board Member - 01/03/2011
Chairman 67 03/11/2009
Director/Board Member - 20/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
20/05/26 Buy

Director

3,600 0.0021%
20/05/26 Buy

Director

430 0.0003%
15/04/26
Myer & Myer Pty Ltd.
SellCompany 9,974,569 5.8334%
Change 5-day change 1-year change 3-year change Capi.($)
-0.33%-2.28%+68.54%+102.02% 367M
-0.71%-8.73%-4.56%+9.80% 46.05B
+0.21%-3.37%+403.76%+534.40% 43.59B
+1.74%-3.63%+42.37%+22.59% 42.35B
+1.38%-4.46%+10.38%+79.88% 38.86B
-1.44%-4.76%+10.26%+38.52% 32.24B
+0.87%-2.81% - - 17.16B
+0.75%-0.99%+23.25%+116.71% 16.28B
-0.31%-3.76%+12.33%+30.49% 14.32B
+1.93%-5.14%+81.55%+39.31% 13.03B
Average +0.41%-4.48%+71.99%+108.19% 26.42B
Weighted average by Cap. +0.40%-5.09%+87.25%+129.24%

Financials

2027 *2028 *
Net sales 107M 76.78M 66.16M 62.64M 56.78M 107M 7.34B 744M 286M 3.73B 288M 282M 11.79B 122M 87.48M 75.37M 71.37M 64.69M 121M 8.36B 848M 326M 4.25B 329M 321M 13.44B
Net income 21.71M 15.57M 13.42M 12.7M 11.51M 21.6M 1.49B 151M 58.02M 757M 58.48M 57.2M 2.39B 26.49M 19M 16.37M 15.5M 14.05M 26.36M 1.82B 184M 70.8M 924M 71.36M 69.8M 2.92B
Net Debt -61.87M -44.38M -38.23M -36.2M -32.81M -61.56M -4.24B -430M -165M -2.16B -167M -163M -6.82B -75.6M -54.22M -46.72M -44.23M -40.09M -75.22M -5.18B -525M -202M -2.64B -204M -199M -8.33B
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
11/09/26 A$3.000 -0.33% 67,032
10/09/26 A$3.010 -2.90% 182,365
09/09/26 A$3.100 +1.64% 436,334
08/09/26 A$3.050 +1.67% 648,703
07/09/26 A$3.000 -2.91% 198,402
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.000AUD
Average target price
3.570AUD
Spread / Average Target
+19.00%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!